Grafa
Paragon Care signals pharmacy receivership recoveries
Image for illustrative purposes only. Not a real photo.

Paragon Care signals pharmacy receivership recoveries

Share

Paragon Care (ASX:PGC) issued a market update regarding its financial exposure to the receivership of the Infinity Retail Pharmacy Group.

Following the appointment of receivers and administrators to the Infinity Group in December 2025, Paragon Care conducted a review of its historical trading receivables, ultimately recognising a 100% provision against the debts in its H1 FY26 financial results.

The analysis indicates that Paragon Care could recoup between $11.7 million and $15.8 million from the administration process, representing a 24% to 32.5% recovery rate of its outstanding exposure.

The estimated return is prior to enforcing additional guarantees obtained from Infinity Group’s owners and directors.

The company has already secured a $3.4 million cash recovery from the Australian Taxation Office for GST previously paid on the Infinity Group receivable.

The company forecasts its FY26 revenue to reach approximately $3.7 billion.

Underlying EBITDA is expected to land between $95 million and $100 million, a figure that includes the impact of the Haju acquisition completed on April 1.

Additionally, net debt is projected to sit between 2 and 2.5 times EBITDA, assuming a full year of contribution from recent acquisitions.

Management stated they will continue to update shareholders as new information emerges.

Frequently asked questions

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.